Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology_DNA, RNA, RNAi, siRNA & mRNA

Santaris Pharma

Parents

2014: Roche to acquire Santaris Pharma to expand discovery and development of RNA-targeting medicines
biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, is delivering on the promise of RNA-targeted medicines
San Diego, California
The Locked Nucleic Acid (LNA) Drug Platform and Drug Discovery Engine developed by Santaris Pharma A/S combine the Company’s proprietary LNA chemistry with its highly specialized and targeted drug development capabilities to rapidly deliver potent single-s